Evaluation of Platelet Aggregation and Adenosine Levels in Patients With Coronary Artery Disease and Chronic Kidney Dysfunction Taking Dual Antiplatelet Therapy With Aspirin and Clopidogrel or Ticagrelor
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Dec 2017 Status changed from not yet recruiting to recruiting.
- 24 Oct 2017 Planned initiation date changed from 1 Jul 2017 to 1 Nov 2017.